McCulloch Kevin

Track

Insider profile

Performance

Overall performance
3.4
Performance over holding periods
3.4
30 days 90 days 120 days
Average return 24% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
McCulloch Kevin's trades of Xeris Biopharma Holdings, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-10-02 2026-10-01
PlS Planned sale
7,432 -13.5%
270.32
US$3,565,414 		7,432 -13.5% 270.32 US$3,565,414
2026-09-29 2026-09-28
PlS Planned sale
56,891 -20.3%
494.72
US$218,208 		56,891 -20.3% 494.72 US$218,208
2026-09-28 2026-09-28
PrS Proposed sale
12,411
428.97
US$1,078,504 		12,411 428.97 US$1,078,504
2026-09-01 2026-09-01
PlS Planned sale
15,000 -0.9%
8.49
US$127,308 		15,000 -0.9% 8.49 US$127,308
2026-08-04 2026-08-03
PlS Planned sale
15,000 -0.9%
8.02
US$120,240 		15,000 -0.9% 8.02 US$120,240
2026-07-02 2026-07-01
PlS Planned sale
90,000 -5.1%
8.03
US$722,511 		90,000 -5.1% 8.03 US$722,511
2026-07-01 2026-07-01
PrS Proposed sale
120,000
7.92
US$950,400 		120,000 7.92 US$950,400
2026-01-09 2026-01-08
PlS Planned sale
15,000 -0.9%
8.00
US$120,000 		15,000 -0.9% 8.00 US$120,000
2026-01-08 2026-01-08
PrS Proposed sale
60,000
7.21
US$432,600 		60,000 7.21 US$432,600
2025-06-16 2025-06-13
B Purchase
25,000 +1.5%
4.38
US$109,475 		25,000 +1.5% 4.38 US$109,475